China Kexing New Crown Vaccine is approved in South Africa to go public

On June 24, local time, the South African Sanitary Products Regulatory Bureau (SAHPRA) announced that it had approved the China Kexing New Crown Vaccine on June 14th to be listed in South Africa, for the country's 18 to 59 -year -old adult vaccination The two -dose interval is 14 to 28 days.

Since the South African Health Products Regulatory Bureau (SAHPRA) announced in July 2021, Callefu has timely disclosed the results of clinical trials conducted in South Africa in South Africa, and abide by the drug alert activities in the risk management plan Requirements are required to regularly submit vaccine safety renewal. As of now, the results of the relevant research have shown that the safety and effectiveness of the new crown vaccine of the Koxing crown are good.

As of January this year, the Koxing New Crown Vaccine has been approved for emergency use or conditions in 20 countries, regions and international organizations in Africa, and has supplied nearly 100 million new crown vaccines to more than 10 African countries and regions.

At the same time, China Kexing has opened a localized irrigation packaging production in African countries such as Egypt and Algeria since 2021 to meet the local epidemic prevention needs. So far, it has cooperated with more than 48 million new crown vaccines. In April of this year, the automated cold storage of the Egypt's establishment of Egypt's establishment of 150 million vaccines was officially started. After the cold storage was completed, it will become the largest vaccine storage center in Egypt and even Africa to further improve the vaccine supply chain in Africa.

As of now, the Koxing New Crown Vaccine has been approved for emergency use in over 60 countries, regions and international organizations around the world, and provided nearly 2.9 billion doses to the world.

(Source: People's Daily)

【Edit: Shang Pei】

- END -